HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- methoxy- N- ((6- (1- methyl- 4- (methylamino)- 1,6- dihydroimiazo(4,5- d)pyrrolo(2,3- b)pyridin- 7- yl)pyridin- 2- yl)methyl)acetamide

structure in first source

Also Known As:

BMS 066; BMS-066; BMS066

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Acetamides: 21
    - 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimiazo(4,5-d)pyrrolo(2,3-b)pyridin-7-yl)pyridin-2-yl)methyl)acetamide: 1
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - Acetamides: 21
        2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimiazo(4,5-d)pyrrolo(2,3-b)pyridin-7-yl)pyridin-2-yl)methyl)acetamide: 1
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimiazo(4,5-d)pyrrolo(2,3-b)pyridin-7-yl)pyridin-2-yl)methyl)acetamide: 1

Experts

1.	Booth-Lute, Hollie: 1 article (11/2009)
2.	Burke, James R: 1 article (11/2009)
3.	Chen, Laishun: 1 article (11/2009)
4.	Cheng, Lihong: 1 article (11/2009)
5.	Darienzo, Celia J: 1 article (11/2009)
6.	Davies, Paul: 1 article (11/2009)
7.	Gillooly, Kathleen M: 1 article (11/2009)
8.	Gregor, Kurt R: 1 article (11/2009)
9.	Kempson, James: 1 article (11/2009)
10.	Kukral, Daniel W: 1 article (11/2009)

Related Diseases

1.	Experimental Arthritis 11/01/2009 - "Investigations of its pharmacology in rodent models of experimental arthritis showed that BMS-066 at doses of 5 and 10 mg/kg once daily was effective at protecting rats against adjuvant-induced arthritis, despite showing only weak inhibition at 10 mg/kg against a pharmacodymanic model of tumor necrosis factor alpha production in rats challenged with lipopolysaccharide. "
2.	Arthritis (Polyarthritis) 11/01/2009 - "Investigations of its pharmacology in rodent models of experimental arthritis showed that BMS-066 at doses of 5 and 10 mg/kg once daily was effective at protecting rats against adjuvant-induced arthritis, despite showing only weak inhibition at 10 mg/kg against a pharmacodymanic model of tumor necrosis factor alpha production in rats challenged with lipopolysaccharide. "

Related Drugs and Biologics

1.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2.	Lipopolysaccharides
3.	Dihydrotachysterol (AT 10)